Mitesco (MITI) 10-Q 4 Jun 18 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 08, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	True Nature Holding, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		22,810,997
Amendment Flag	false
Entity Central Index Key	802,257
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 0	$ 0
Total current assets	0	0
Total Assets	0	0
Current liabilities
Accounts payable	772,398	766,356
Accrued liabilities	79,561	147,894
Due to related parties	8,503	91,066
Accrued interest	55,576	50,665
Convertible note payable	60,000	60,000
Convertible note payable, in default	196,270	196,270
Note payable - related party	75,000	75,000
Total current liabilities	1,247,308	1,387,251
Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock, $0.01 par value, 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2018 and December 31, 2017	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized, 20,835,997 and 18,930,874 shares issued and outstanding as of March 31, 2018 and December 31, 2017	208,360	189,309
Additional paid-in capital	4,841,045	4,659,713
Stock payable	39,886	39,886
Accumulated deficit	(6,336,599)	(6,276,159)
Total (deficiency in) stockholders’ equity	(1,247,308)	(1,387,251)
Total liabilities and stockholders’ equity	$ 0	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	20,835,997	18,930,874
Common stock, shares outstanding	20,835,997	18,930,874

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenue	$ 0	$ 0
Operating expenses:
General and administrative	53,279	228,368
Total operating expenses	53,279	228,368
Net Operating Loss	(53,279)	(228,368)
Other income (expense):
Interest expense	(7,161)	(4,911)
Total other expense	(7,161)	(4,911)
Loss before provision for income taxes	(60,440)	(233,279)
Provision for income taxes	0	0
Net loss	$ (60,440)	$ (233,279)
Net loss per share - basic (in Dollars per share)	$ 0	$ (0.01)
Net loss per share - diluted (in Dollars per share)	$ 0	$ (0.01)
Weighted average shares outstanding - basic (in Shares)	20,222,124	17,939,636
Weighted average shares outstanding - diluted (in Shares)	20,222,124	17,939,636

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (60,440)	$ (233,279)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on conversion of accrued interest	2,250	0
Stock based compensation	0	137,534
Changes in assets and liabilities:
Prepaid expenses	0	(7,292)
Accounts payable	52,842	65,390
Accrued liabilities	25,000	(8,239)
Due to related parties	(24,563)	19,030
Accrued interest	4,911	4,911
Net cash used in operating activities	0	(21,945)
CASH FLOWS FROM FINANCING ACTIVITIES
Sale of common stock, net of issuance costs	0	22,000
Net cash provided by financing activities	0	22,000
Net increase (decrease) in cash and cash equivalents	0	55
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	55
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	0	0
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of debt to common stock	$ 198,133	$ 32,000

Note 1 - Description of Busines

Note 1 - Description of Business	3 Months Ended
	Mar. 31, 2018
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 – Description of Business True Nature Holding, Inc. (the “Company”), previously known as Trunity Holdings, Inc., became a publicly-traded company through a reverse merger with Brain Tree International, Inc., a Utah corporation (“BTI”). BTI was incorporated on July 26, 1983 to specialize in the development of high technology products or applications including, but not limited to, electronics, computerized technology, new technological product fields, and precious metals. Trunity Holdings, Inc. was the parent company of the prior educational business, named Trunity, Inc., which was formed on July 28, 2009 through the acquisition of certain intellectual property by its three founders. True Nature Holding, Inc. is a corporation organized under the laws of the state of Delaware with principal offices located in Atlanta, Georgia. On January 16, 2016, the Company changed the equity structure that included a reverse split of 1 for 101, such that all holders of 101 shares of common stock issued and outstanding prior to the effective date of the reverse split would own 1 share of common stock upon the effect date of the reverse split. In addition, the Company amended its Articles of Incorporation (i) to increase its authorized capital stock to 510,000,000 shares which consists of 500,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share and (ii) to change its name from Trunity Holdings, Inc. to True Nature Holding, Inc. (there was no change in the stock symbol “TNTY”).

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2018
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies Basis of Accounting Use of Estimates - Comprehensive Loss – Cash - Revenue Recognition- Stock-Based Compensation - Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant. Convertible Instruments Common Stock Purchase Warrants- Stockholders’ Equity- Per Share Data- The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of March 31, 2018 and December 31, 2017, the Company had 142,653 warrants outstanding and 67,879 options outstanding excluded from calculation of diluted net loss. Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012. Business Combinations- · future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and · discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the consolidated financial position, statements of operations or cash flows in the period of the change in the estimate. Impairment of Long-Lived Assets- Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3. Recently Issued Accounting Standards-

Note 3 - Financial Condition an

Note 3 - Financial Condition and Going Concern	3 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	N ote 3 – Financial Condition and Going Concern As of March 31 2018, the Company had no cash on hand and current liabilities of $1,247,308, and has incurred a loss from operations. True Nature Holding’s principal operation is the acquisition of compounding pharmacy companies. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan. As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. The Company believes that the necessary capital will be raised and has entered into discussions to do so with certain individuals and companies. However, as of the date of these consolidated financial statements, no formal agreement exists. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions.

Note 4 - Related Party Transact

Note 4 - Related Party Transactions	3 Months Ended
	Mar. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 4 – Related Party Transactions Three month ended March 31, 2018: On January 29, 2018, the Company converted outstanding accounts payable due to an investor in the amount of $54,815 for 527,064 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $54,815, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded. On January 29, 2018, the Company converted accrued officer compensation in the amount of $93,333 into 897,432 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $93,333, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded. The Company accrued officers compensation to during the three months ended March 31, 2018 in the amount of $25,000 and imputed interest expense of $2,250 on a note payable to a related party in the amount of $75,000 (see note 5). Three months ended March 31, 2017: On January 24, 2017, the Board granted to a member of Board of Directors 25,000 shares of restricted common stock as consideration for services. The Member of the Board of Directors abstained from the vote as to not be voting on his own issuance. The value for the issuance was $2,500, based on the closing price on the date of the grant. On January 25, 2017, the Board granted the newly appointed CEO and CFO 500,000 shares of restricted common shares as part of his employment compensation. The shares are subject to reverse vesting that requires him to stay with the company for three (3) years (1/3 per year) and achieve certain management objectives to keep all of the shares. The expense to the Company was $15,236 during the three months ended March 31, 2017. On February 7, 2017, the Board appointed one (1) additional member to the Board of Directors. The appointed member shall receive the customary 100,000 shares of restricted common stock for their service. The cost to the Company for this issuance is $11,000, based on the closing price on the date of the grant. The same candidate offered to buy 200,000 shares of restricted common stock at the same time. The consideration for the sale was $22,000. The transaction has no impact on earnings as the shares were priced at the same cost as the closing price on the date of the purchase. On February 14, 2017, the Board of Directors for True Nature Holding, Inc. authorized the issuance of restricted common stock to a shareholder for consulting services. This calculation is based on February 14, 2017 and at the market close of $0.14 per share; hereby converting the debts which are currently owed and equates to 258,637 shares, for a total cost to the Company of $36,210 , based on the closing price on the date of the grant. On February 14, 2017, the Board of Directors for True Nature Holding, Inc. authorized the issuance of restricted common stock to convert amounts owed to a vendor. This calculation is based on February 14, 2017 and at the market close of $0.14 per share; hereby converting $20,000 of debt in outstanding legal fees and expenses which are currently owed as of January 31, 2017, to 142,857 shares, for a total cost to the Company of $20,000. As the conversion amount equals the share value, no gain or loss was recorded. On February 14, 2017, the Board authorized the issuance of restricted shares to convert the last 3 month’s salary ($4,000 per month for a total owed of $12,000) of 2016 owed to a Director serving as its Interim President. The price per share used was the closing price of $0.14 per share which equates to 85,714 shares of TNTY. This action hereby settles all outstanding past debts owed to the Director by TNTY up to February 14, 2017. As the conversion amount equals the share value, no gain or loss was recorded. On February 14, 2017, the Board granted the newly appointed COO 500,000 shares of restricted common shares as part of his employment compensation. The shares are subject to reverse vesting that requires him to stay with the company for three (3) years (1/3 per year) and achieve certain management objectives in order to keep all of the shares. The expense to the Company was $11,088. On March 8, 2017, the Board authorized the issuance of 100,000 restricted common stock to a newly appointed member of the non-executive Advisory Board. The stock was priced at the closing price of the stock at that date which was $0.30. The expense to the Company was $30,000.

Note 5 - Debt

Note 5 - Debt	3 Months Ended
	Mar. 31, 2018
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 5 – Debt March 2016 Convertible Note A On March 18, 2016, the Company issued a 12% Convertible Promissory Note (the “Convertible Note A”) in the principal amount of $60,000 to a lender. Upon issuance of the Convertible A Note, the lender was awarded 15,000 restricted common stock as an origination fee which includes piggy back registration rights. On September 19, 2016, the Company issued the lender an additional 15,000 restricted common stock at a price of $0.30 per share to extend the term of the loan agreement indefinitely. The cost to the Company was $4,050 in interest expense. On August 10, 2017, the Company issued 25,000 shares of common stock with a fair value of $3,750 for accrued interest through August 1, 2017 in the amount of $7,860. In April 2018, the Company committed to issue 72,000 shares of common stock as consideration for extending the due date of the Convertible Note A to July 1, 2018. Accrued interest at March 31, 2018 and December 31, 2017, was $12,660 and $10,860, respectively. Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company is obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors. The Company allocated the face value of the Convertible Note A to the shares and the note based on relative fair values, and the amount allocated to the shares of $18,750 was recorded as a discount against the note. The beneficial conversion feature of $9,375 was recorded as a debt discount with an offsetting entry to additional paid-in capital decreasing the note payable and increasing debt discount. The debt discount is being amortized to interest expense over the term of the debt. For the year ended December 31, 2016, debt discount amortization related to the Convertible Note A was $28,125. There was no amortization of the discount during the three months ended March 31, 2018. May 2016 Convertible Note B On May 19, 2016, the Company issued a 10% Convertible Promissory Note (the “Convertible Note B”) in the principal amount of $100,000 to a lender. Upon issuance of the Convertible Note B, the lender was awarded 24-month warrants to purchase up to 66,666 shares of the Company’s common stock at an exercise price of $2.50 per share. The warrants were valued at $103,086 with $100,000 as a debt discount; the additional $3,086 was expensed as additional interest expense. The debt discount was fully amortized during the year ended December 31, 2016. This obligation, including all warrants, penalties and interest due was cancelled as of September 30, 2016 in consideration of the issuance of 400,000 shares of restricted common stock valued at $120,000. At the time of conversion, the principal amount of the note was approximately $100,000 and total accrued interest thereon was $3,671. Therefore, as a result of the conversion, a loss of $16,329 recognized during the year ended December 31, 2018. August 2014 Convertible Debentures (Series C) As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series C Convertible Debenture (the “Series C Debenture”) in August 2014 with an aggregate face value of $100,000 in exchange for the cancellation of Series B Convertible Debentures with a carrying value of $110,833 did not convert such debenture. The Series C Debenture accrues interest at an annual rate of 10%, matured November 2015, and is convertible into our common stock at a conversion rate of $20.20 per share. The holders of the Series C Debenture also received five year warrants to acquire up to 4,950 shares post-split of common stock for an exercise price of $20.20 per share,. The former educational business allocated the face value of the Series C Debenture to the warrants and the debentures based on its relative fair values, and allocated to the warrants, which was recorded as a discount against the Series C Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. As of March 31, 2018 and December 31, 2017, the carrying value of this Series C Debenture was $110,833 and accrued interest expense of $38,274 and $35,504, respectively. The Series C Debenture is currently in default. November 2014 Convertible Debentures (Series D) As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series D Convertible Debenture (the “Series D Debenture”) in November 2014 with an aggregate face value of $10,000 in exchange for the cancellation of Series B Convertible Debenture with a carrying value of $11,333 did not participate in the debt conversion restructuring. The Series D Debenture accrues interest at an annual rate of 12%, matured November 2015, and is convertible into our common stock at a conversion rate of $16.67 per share. The holders of the Series D Debenture also received five year warrants to acquire up to 495 shares of common stock for an exercise price of $20.20 per share on a post-split basis. The former educational business allocated the face value of the Series D Debenture to the warrants and the debentures based on their relative fair values, and allocated to the warrants, which was recorded as a discount against the Series D Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. As of March 31, 2018 and December 31, 2017, the carrying value of the Series D Debenture was $11,333 and accrued interest expense of $4,641 and $4,301, respectively. The Series D Debenture is currently in default. Short term loan As a result of the acquisition of P3 Compounding of Georgia, LLC (“P3”) the Company had a short-term convertible note with a loan agency in the principal amount of $52,000 for the purchase of future sales and credit card receivables of P3. Under the terms of the receivable purchase agreement, the Company purchased an advance of $50,000 plus $2,000 for origination costs with a 10.5% daily interest rate to be repaid over 160 days at a repayment amount of $451.75 per day. Upon maturity, the total repayment amount will be $72,280. As of December 31, 2016 the carrying value of this short-term loan was $26,925. For year ending December 31, 2016, no interest expense related to this loan was recorded in the Company’s consolidated financial statements as the effective date of acquisition was the last day of the quarter. The origination fee and interest were recorded as debt discount on the date of issuance in the amount of $22,280 and $22,280 was amortized during the year ending December 31, 2016. Although the note is in default, the lender and the Company have agreed not to take any action until such time as repayment can be arranged. July 2017 Note On July 10, 2017, the Company negotiated the reclassification of $75,000 in accounts payable to a loan payable (the “July 2017 Note”). The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding. The July 2017 Note bears no interest; however, if it is not paid by the due date, interest will accrue at the rate of 12% per year. During the three months ended March 31, 2018 the Company imputed interest in the amount of $2,250.

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit	3 Months Ended
	Mar. 31, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 6 – Stockholders’ Deficit Sale of Common Stock During the three months ending March 31, 2018, the Company had no sales of common stock for cash. During the three months ending March 31, 2017, the Company raised gross proceeds of $22,000 through the sale of 200,000 shares of common stock to a new member of the Board of Directors at a price of $0.11 per share. Shares for Stock Based Compensation During the three months ending March 31, 2018, the Company issued 1,347,431 restricted shares of the Company’s common stock at valued $140,133 in exchange for services conducted on behalf of the Company. This amount was previously accrued. The value of these shares was based on the closing market price on the respective date of grant. During the three months ending March 31, 2017, in connection with services rendered, the Company issued 583,637, restricted shares of the Company’s common stock at valued $136,034 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant. Shares issued for convertible note payable issuance During the three months ending March 31, 2018, the Company did not issue any shares related to a convertible note payable. During the three months ending March 31, 2017, in connection with conversion of a six-month convertible promissory note, the Company issued 15,000 shares of the Company’s common stock with a fair value of $2,100 that was valued based on the closing market price on the date of the grant. Shares issued for conversion of accounts payable During the three months ending March 31, 2018, the Company issued 527,064 shares valued at $54,815 to settle outstanding accounts payable. There was no gain or loss on the transaction because the fair value of the shares issued equaled the fair value of the accounts payable settled. During the three months ending March 31, 2017, the Company issued 228,571 shares valued at $32,000 to settle outstanding accounts payable. There was no gain or loss on the transaction because the fair value of the shares issued equaled the fair value of the accounts payable settled.

Note 7 - Stock Options

Note 7 - Stock Options	3 Months Ended
	Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7 – Stock Options A summary of options issued, exercised and cancelled are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value ($) Outstanding at December 31, 2017 67,879 $ 21.40 5.17 — Granted — — — — Cancelled — — — — Outstanding at March 31, 2018 67,879 $ 21.40 4.92 — Exercisable at March 31, 2018 67,879 $ 21.40 4.92 —

Note 8 - Stock Warrants

Note 8 - Stock Warrants	3 Months Ended
	Mar. 31, 2018
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 8 – Stock Warrants Subsequent to the restructuring of the Company and the spin-out, the Company had warrants to purchase common stock outstanding that were not terminated and have continued as part of the operations as detailed below. The warrants were adjusted for a 1 for 101 stock split due to the spin-out and restructuring plan as authorized. All warrants outstanding as of March 31, 2018 are scheduled to expire at various dates through 2019. A summary of warrants issued, exercised and expired are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Outstanding at December 31, 2017 142,653 $ 17.42 1.25 Granted — — — Expired — — — Outstanding at March 31, 2018 142,653 $ 17.42 1.00 Exercisable at March 31, 2018 142,653 $ 17.42 1.00

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 9 – Commitments and Contingencies Legal National Council for Science and the Environment, Inc. v. Trunity Holdings, Inc., Case No. 2015 CA 009726 B, Superior Court for the District of Columbia, Civil Division. This action was filed on December 16, 2015 by the National Council for Science and the Environment, Inc. (“NCSE”) in the state court in the District of Columbia against Trunity Holdings, Inc. (“Trunity”) and alleges claims for breach of contract. Acknowledgement of indebtedness and settlement agreement and quantum meruit arising out of an agreement entered into between NCSE and Trunity in 2014. The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case. The Company, in its answer dated January 27, 2016, denied the material allegations made by NCSE, asserted a number of affirmative defenses and filed a counterclaim alleging claims for fraud, negligent misrepresentation, breach of fiduciary duty, breach of contract and unjust enrichment. In its counterclaim, the Company sought actual and compensatory damages against NCSE that it believes exceed the amount sought by NCSE on its claims, pre-judgment interest, punitive damages and all costs and expenses, including attorney’s fees, incurred by the Company in bringing its claims against NCSE. On September 23, 2016, the Company settled this obligation with an agreement to pay $48,500 to NCSE if paid by November 4, 2016, and $75,000 if paid later. The Company has not paid the amounts as of the date of this filing, and has recorded the obligation at $75,000. Carlton Fields Jorden Burt, P.A. vs. True Nature Holding, Inc., f/k/a/ Trunity Holdings, Inc. This action was filed on May 18, 2017 by a law firm that represented the Company prior to the spin-out of the educational software business in 2016 with the intent of collection past due invoices in the aggregate amount of $241,828. The Company believes it has strong defenses against any such action and anticipates a settlement upon completion of certain funding activities. The Company has recorded a liability in the amount of $241,828 on its balance sheet at March 31, 2018. 230 Commerce Way, LLC vs. Trunity, Inc. A former landlord of the Company has filed an action in New Hampshire to collect on rent from a list that existed prior to 2013. In January 2018 this action was settled by the spin out, Trunity, Inc. for a cash payment of $65,000. Trunity, Inc. The spin-out that now owns the former educational software business has been informed that they owe the Company from the obligations of the NCSE settlement, and the costs of the legal action. We intend to take all actions available to us to collect on these amounts.

Note 10 - Subsequent Events

Note 10 - Subsequent Events	3 Months Ended
	Mar. 31, 2018
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 10 – Subsequent Events In April 2018 the Company Appointed Mr. Jay Morton to the positions of President and Interim Chief Executive Officer (CEO), effective April 1, 2018. Mr. Morton, age 51, founded Local Pet RX in 2014, where he and four other shareholders have developed a “telemedicine” like application for use by pharmacies and veterinary clinics, aimed at processing orders from the veterinary clinics online, while allowing the end user pet owners to interface with both the veterinary clinic and the filling pharmacy business. In April 2018, the Company agreed to issue 72,000 shares of common stock to a lender as consideration for extending the due date of a note payable in the principal amount of $60,000 to July 1, 2018. See note 5. In May 2018, the Company issued the following shares of common stock: 500,000 shares to its President and Interim Chief Executive Officer pursuant to an employment agreement; 600,000 shares to a consultant for services; 600,000 shares to a consultant for services; 75,000 shares to an investor for accrued interest on a note payable; and 200,000 shares to a consultant for services. We evaluated subsequent events after the balance sheet date through the date the financial statements were issued. Other than the events described above, we did not identify any additional material events or transactions which occurred during this subsequent event reporting period that required further recognition or disclosure in these financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2018
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Accounting
Use of Estimates, Policy [Policy Text Block]	Use of Estimates -
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Loss –
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash -
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition-
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation - Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant.
Convertible Instruments, Policy [Policy Text Block]	Convertible Instruments
Warrants, Policy [Policy Text Block]	Common Stock Purchase Warrants-
Stockholders' Equity, Policy [Policy Text Block]	Stockholders’ Equity-
Earnings Per Share, Policy [Policy Text Block]	Per Share Data- The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are antidilutive for the periods presented. As of March 31, 2018 and December 31, 2017, the Company had 142,653 warrants outstanding and 67,879 options outstanding excluded from calculation of diluted net loss.
Income Tax, Policy [Policy Text Block]	Income Taxes- Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.
Business Combinations Policy [Policy Text Block]	Business Combinations- · future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and · discount rates utilized in valuation estimates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets-
Fair Value of Financial Instruments, Policy [Policy Text Block]	Financial Instruments and Fair Values- Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards-

Note 7 - Stock Options (Tables)

Note 7 - Stock Options (Tables)	3 Months Ended
	Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of options issued, exercised and cancelled are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value ($) Outstanding at December 31, 2017 67,879 $ 21.40 5.17 — Granted — — — — Cancelled — — — — Outstanding at March 31, 2018 67,879 $ 21.40 4.92 — Exercisable at March 31, 2018 67,879 $ 21.40 4.92 —

Note 8 - Stock Warrants (Tables

Note 8 - Stock Warrants (Tables)	3 Months Ended
	Mar. 31, 2018
Disclosure Text Block Supplement [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	A summary of warrants issued, exercised and expired are as follows: Shares Weighted- Average Exercise Price ($) Weighted- Average Remaining Contractual Term Outstanding at December 31, 2017 142,653 $ 17.42 1.25 Granted — — — Expired — — — Outstanding at March 31, 2018 142,653 $ 17.42 1.00 Exercisable at March 31, 2018 142,653 $ 17.42 1.00

Note 1 - Description of Busin19

Note 1 - Description of Business (Details) - $ / shares	Jan. 16, 2016	Mar. 31, 2018	Dec. 31, 2017
Disclosure Text Block [Abstract]
Stockholders' Equity, Reverse Stock Split	1 for 101
Capital Stock, Share Authorized		510,000,000
Common Stock, Shares Authorized		500,000,000	500,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.01	$ 0.01
Preferred Stock, Shares Authorized		10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.01	$ 0.01

Note 2 - Summary of Significa20

Note 2 - Summary of Significant Accounting Policies (Details) - shares	Jan. 16, 2016	Mar. 31, 2018	Dec. 31, 2017
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	1 for 101
Employee Stock Option [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		142,653	142,653
Warrant [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		67,879	67,879

Note 3 - Financial Condition 21

Note 3 - Financial Condition and Going Concern (Details) - USD ($)	Mar. 31, 2018	Dec. 31, 2017	Mar. 31, 2017	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 0	$ 0	$ 55	$ 0
Liabilities, Current	$ 1,247,308	$ 1,387,251

Note 4 - Related Party Transa22

Note 4 - Related Party Transactions (Details)	Jan. 29, 2018USD ($)shares	Aug. 10, 2017USD ($)	Mar. 08, 2017USD ($)$ / sharesshares	Feb. 14, 2017USD ($)$ / sharesshares	Feb. 07, 2017USD ($)shares	Jan. 25, 2017USD ($)shares	Jan. 24, 2017USD ($)shares	Mar. 31, 2018USD ($)shares	Mar. 31, 2017USD ($)$ / sharesshares
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount				$ 12,000				$ 198,133	$ 32,000
Stock Issued During Period, Shares, Other (in Shares) | shares				85,714
Debt Conversion, Converted Instrument, Amount		$ 7,860
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures (in Shares) | shares			100,000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures			$ 30,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares				500,000		500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights				The shares are subject to reverse vesting that requires him to stay with the company for three (3) years (1/3 per year) and achieve certain management objectives in order to keep all of the shares		The shares are subject to reverse vesting that requires him to stay with the company for three (3) years (1/3 per year) and achieve certain management objectives to keep all of the shares.
Allocated Share-based Compensation Expense						$ 15,236
Stock Issued During Period, Value, Restricted Stock Award, Gross				$ 11,088
Share Price (in Dollars per share) | $ / shares				$ 0.14
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares									583,637
Stock Issued During Period, Value, Issued for Services									$ 136,034
Shares Issued, Price Per Share (in Dollars per share) | $ / shares			$ 0.30
Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 93,333
Stock Issued During Period, Shares, Other (in Shares) | shares	897,432
Stock Issued During Period, Value, Other	$ 93,333
Debt Conversion, Converted Instrument, Amount								25,000
Interest Expense, Related Party								2,250
Debt Instrument, Face Amount								$ 75,000
Director [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures (in Shares) | shares							25,000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures							$ 2,500
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares) | shares					100,000
Number of Board Members					1
Stock Issued During Period, Value, Restricted Stock Award, Gross					$ 11,000
Stock Issued During Period, Shares, New Issues (in Shares) | shares					200,000				200,000
Stock Issued During Period, Value, New Issues					$ 22,000				$ 22,000
Shares Issued, Price Per Share (in Dollars per share) | $ / shares									$ 0.11
Shares Issued for Services [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Share Price (in Dollars per share) | $ / shares				$ 0.14
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares				258,637
Stock Issued During Period, Value, Issued for Services				$ 36,210
Accounts Payable [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 54,815			$ 20,000
Stock Issued During Period, Shares, Other (in Shares) | shares	527,064			142,857				527,064	228,571
Stock Issued During Period, Value, Other	$ 54,815			$ 20,000				$ 54,815	$ 32,000
Share Price (in Dollars per share) | $ / shares				$ 0.14
Employment Agreement, Monthly Salary 2017 [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount				$ 4,000

Note 5 - Debt (Details)

Note 5 - Debt (Details) - USD ($)

Aug. 10, 2017

Jul. 10, 2017

Feb. 14, 2017

Dec. 30, 2016

Sep. 30, 2016

Sep. 19, 2016

May 19, 2016

Mar. 18, 2016

Nov. 30, 2014

Aug. 31, 2014

May 31, 2018

Apr. 30, 2018

Mar. 31, 2018

Mar. 31, 2017

Dec. 31, 2017

Dec. 31, 2016

Mar. 08, 2017

Note 5 - Debt (Details) [Line Items]

Stock Issued During Period, Shares, Other (in Shares)

85,714

Shares Issued, Price Per Share (in Dollars per share)

$ 0.30

Stock Issued During Period, Shares, Conversion of Convertible Securities (in Shares)

25,000

Stock Issued During Period, Value, Conversion of Convertible Securities

$ 3,750

Debt Conversion, Converted Instrument, Amount

$ 7,860

Interest Payable, Current

$ 55,576

$ 50,665

Class of Warrant or Rights, Granted (in Shares)

0

Debt Conversion, Original Debt, Amount

$ 12,000

$ 198,133

$ 32,000

P3 Compounding of Georgia, LLC [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.50%

Debt Instrument, Face Amount

$ 52,000

Debt Instrument, Fee Amount

$ 2,000

Debt Instrument, Periodic Payment

451.75

Debt Instrument, Unamortized Discount

22,280

Amortization of Debt Discount (Premium)

22,280

Proceeds from Short-term Debt

$ 50,000

Debt Instrument, Term

160 days

Debt Instrument, Frequency of Periodic Payment

repayment amount of $451.75 per day

Short-term Debt

$ 72,280

Notes Payable

26,925

Convertible Note A [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Face Amount

$ 60,000

Stock Issued During Period, Shares, Other (in Shares)

15,000

15,000

Shares Issued, Price Per Share (in Dollars per share)

$ 0.30

Debt Instrument, Fee Amount

$ 4,050

Interest Payable, Current

12,660

10,860

Debt Instrument, Periodic Payment

$ 1,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 1

Debt Instrument, Unamortized Discount

$ 18,750

Debt Instrument, Convertible, Beneficial Conversion Feature

$ 9,375

Amortization of Debt Discount (Premium)

0

28,125

Convertible Note B [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Face Amount

$ 100,000

Stock Issued During Period, Shares, Other (in Shares)

400,000

Debt Instrument, Unamortized Discount

$ 100,000

Warrant Term

24 months

Class of Warrant or Rights, Granted (in Shares)

66,666

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 2.50

Warrants, Fair Value of Warrants, Granted

$ 103,086

Interest Expense, Debt

$ 3,086

Stock Issued During Period, Value, Other

$ 120,000

Gain (Loss) on Extinguishment of Debt

(16,329)

Series C Debenture [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

10.00%

Debt Instrument, Face Amount

$ 100,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 20.20

Warrant Term

5 years

Class of Warrant or Rights, Granted (in Shares)

4,950

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 20.20

Interest Expense, Debt

35,504

38,274

Convertible Debt

$ 110,833

110,833

110,833

Series D Debenture [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Face Amount

$ 10,000

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

$ 16.67

Warrant Term

5 years

Class of Warrant or Rights, Granted (in Shares)

495

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$ 20.20

Interest Expense, Debt

4,641

4,301

Convertible Debt

$ 11,333

11,333

$ 11,333

July 2017 Note [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

12.00%

Debt Instrument, Face Amount

$ 75,000

Interest Expense, Debt

$ 2,250

Debt Instrument, Maturity Date, Description

The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding.

Subsequent Event [Member]

Note 5 - Debt (Details) [Line Items]

Debt Instrument, Face Amount

$ 60,000

Stock Issued During Period, Shares, Other (in Shares)

600,000

72,000

Extending the Convertible Debt Due Date [Member] | Subsequent Event [Member]

Note 5 - Debt (Details) [Line Items]

Debt Conversion, Converted Instrument, Shares Issued (in Shares)

72,000

Principal [Member] | Convertible Note B [Member]

Note 5 - Debt (Details) [Line Items]

Debt Conversion, Original Debt, Amount

100,000

Interest Expense [Member] | Convertible Note B [Member]

Note 5 - Debt (Details) [Line Items]

Debt Conversion, Original Debt, Amount

$ 3,671

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit (Details) - USD ($)	Jan. 29, 2018	Feb. 14, 2017	Feb. 07, 2017	Mar. 31, 2018	Mar. 31, 2017	Mar. 08, 2017
Note 6 - Stockholders' Deficit (Details) [Line Items]
Shares Issued, Price Per Share						$ 0.30
Stock Issued During Period, Shares, Issued for Services					583,637
Stock Issued During Period, Value, Issued for Services					$ 136,034
Debt Conversion, Original Debt, Amount		$ 12,000		$ 198,133	32,000
Stock Issued During Period, Shares, Other		85,714
Director [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Value, New Issues			$ 22,000		$ 22,000
Stock Issued During Period, Shares, New Issues			200,000		200,000
Shares Issued, Price Per Share					$ 0.11
Convertible Debt [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued					15,000
Debt Conversion, Original Debt, Amount					$ 2,100
Accrued Compensation [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services				1,347,431
Stock Issued During Period, Value, Issued for Services				$ 140,133
Accounts Payable [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 54,815	$ 20,000
Stock Issued During Period, Shares, Other	527,064	142,857		527,064	228,571
Stock Issued During Period, Value, Other	$ 54,815	$ 20,000		$ 54,815	$ 32,000

Note 7 - Stock Options (Details

Note 7 - Stock Options (Details) - Share-based Compensation, Stock Options, Activity - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Share-based Compensation, Stock Options, Activity [Abstract]
Options Outstanding, Shares		67,879
Options Outstanding, Weighted- Average Exercise Price		$ 21.40
Options Outstanding, Weighted- Average Remaining Contractual Term	4 years 335 days	5 years 62 days
Options Outstanding, Aggregate Intrinsic Value	$ 0	$ 0
Options Exercisable, Shares	67,879
Options Exercisable, Weighted- Average Exercise Price	$ 21.40
Options Exercisable, Weighted- Average Remaining Contractual Term	4 years 335 days
Options Exercisable, Aggregate Intrinsic Value	$ 0
Options Granted, Shares	0
Options Granted, Weighted- Average Exercise Price	$ 0
Options Cancelled, Shares	0
Options Cancelled, Weighted- Average Exercise Price	$ 0
Options Outstanding, Shares	67,879
Options Outstanding, Weighted- Average Exercise Price	$ 21.40

Note 8 - Stock Warrants (Detail

Note 8 - Stock Warrants (Details)	Jan. 16, 2016
Disclosure Text Block Supplement [Abstract]
Stockholders' Equity, Reverse Stock Split	1 for 101

Note 8 - Stock Warrants (Deta27

Note 8 - Stock Warrants (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Warrants, Outstanding		142,653
Warrants, Outstanding Weighted-Average Exercise Price	$ 17.42	$ 17.42
Warrants, Outstanding Weighted-Average Remaining Contractual Terms	1 year	1 year 3 months
Warrants, Exercisable	142,653
Warrants, Exercisable Weighted-Average Exercise Price	$ 17.42
Warrants, Exercisable Weighted-Average Remaining Contractual Terms	1 year
Warrants, Granted	0
Warrants, Granted Weighted-Average Exercise Price	$ 0
Warrants, Expired	0
Warrants, Expired Weighted-Average Exercise Price	$ 0
Warrants, Outstanding	142,653

Note 9 - Commitments and Cont28

Note 9 - Commitments and Contingencies (Details) - USD ($)	May 18, 2017	Nov. 04, 2016	Sep. 23, 2016	Dec. 16, 2015	Jan. 31, 2018	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Loss Contingency, Damages Sought				The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case.
Loss Contingency, Damages Sought, Value	$ 241,828			$ 177,270
Loss Contingency, Damages Awarded, Value		$ 75,000	$ 48,500
Settlement Liabilities, Current						$ 75,000
Estimated Litigation Liability, Current						$ 241,828
Litigation Settlement, Expense					$ 65,000

Note 10 - Subsequent Events (De

Note 10 - Subsequent Events (Details) - USD ($)	Feb. 14, 2017	May 31, 2018	Apr. 30, 2018
Note 10 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, Other	85,714
Subsequent Event [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, Other		600,000	72,000
Debt Instrument, Face Amount (in Dollars)			$ 60,000
Debt Instrument, Maturity Date			Jul. 1, 2018
Stock Issued During Period, Shares, Share-based Compensation, Gross		75,000
Stock Issued During Period, Shares, New Issues		600,000
Stock Issued During Period, Shares, Acquisitions		200,000
Subsequent Event [Member] | President [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross		500,000